A routine check led to months of turmoil for Michael Harrison, but his experience – and survival – left him with an important message for all other men ...

Global Prostate Cancer Diagnostics Market OverviewThe global prostate cancer diagnostics market is projected to grow at a CAGR of approximately 12% during the forecast period, driven by a combination ...

Men diagnosed with prostate cancer have traditionally faced two choices: Do nothing and hope the tumor doesn’t grow between ...

Orthocell Limited is pleased to announce adoption of Remplirtm by Australian urologists is accelerating with the product increasingly being used during prostate cancer surgery in a promising new ...

Cancer is not just a medical diagnosis; itis a financial and emotional crisis. The high costs of treatment, diagnostics,and supportive care often overwhelm families, forcing them to sell ...

Dr Mitch Kaplan, specialist radiologist and medical director of Scan For Life, discusses the tests he recommends to live ...

MRI does not reliably exclude clinically significant prostate cancer in about one quarter of patients receiving active ...

The first men have been invited to take part in Prostate Cancer UK's TRANSFORM trial, kicking off the biggest prostate cancer ...

Multiparametric MRI detects more local recurrences after prostatectomy than prostate-specific membrane antigen PET-CT, with the two showing only moderate agreement.

The Article by Tamim Niazi and colleagues1 on the Prostate Cancer Study 9 (PCS-9) investigated stereotactic body radiotherapy ...

Deep learning-based automated osteoporosis screening may be able to identify patients with low BMD using existing medical images.